Follow @TheHPRA
Contact us
As Gaeilge
My HPRA:
Login
Register
About Us
Medicines
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Medicines
Safety Notices
My HPRA:
Login
Register
About Us
Medicines
COVID-19 vaccines and treatments
Our Role
Medicines Information
Safety Information
Safety Notices
Quality Information
Regulatory Information
News & Events
Special Topics
Emergency Medicines
Emergency Contact Details
Veterinary
Medical Devices
Cosmetics
Controlled Substances
Blood, Tissues, Organs
Beta interferons: - Important Safety Information from Biogen Idec Ltd., Bayer Ltd., Novartis Ireland Limited and Merck Serono Ltd. as approved by the Health Products Regulatory Authority
Notice type:
3rd Party Publications
Date:
03/09/2014
Background Information Or Related Documents:
Important Safety Information communication from Biogen Idec Ltd., Bayer Ltd., Novartis Ireland Limited and Merck Serono Ltd on risk of thrombotic microangiopathy and nephrotic syndrome associated with Beta interferons.
Important Safety Information - Beta interferons
« Back
Date Printed: 18/04/2024